This topic contains a solution. Click here to go to the answer

Author Question: Option A provides 9,000 with probability 50 percent or 11,000 with probability 50 percent. Option B ... (Read 63 times)

lracut11

  • Hero Member
  • *****
  • Posts: 536
Option A provides 9,000 with probability 50 percent or 11,000 with probability 50 percent. Option B provides 8,000 with probability 50 percent or 12,000 with probability 50 percent. For most people the cost of risk associated with B is
 
  A) less than that associated with A.
  B) the same as that associated with A.
  C) exactly twice that associated with A.
  D) more than twice that associated with A.

Question 2

The price in a contestable market is similar to that in a perfectly competitive market because
 
  A) there are barriers to entry.
  B) there are no barriers to entry.
  C) there are many firms in the market.
  D) the firm can earn an economic profit in the long run.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

frankwu0507

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

D

Answer to Question 2

B




lracut11

  • Member
  • Posts: 536
Reply 2 on: Jun 29, 2018
Wow, this really help


brbarasa

  • Member
  • Posts: 308
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

Although puberty usually occurs in the early teenage years, the world's youngest parents were two Chinese children who had their first baby when they were 8 and 9 years of age.

Did you know?

Street names for barbiturates include reds, red devils, yellow jackets, blue heavens, Christmas trees, and rainbows. They are commonly referred to as downers.

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library